- Home
- AEON vs MYNA Comparison
AEON vs MYNA Comparison
Compare AEON & MYNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEON
- MYNA
- Stock Information
- Founded
- AEON N/A
- MYNA 2009
- Country
- AEON United States
- MYNA Germany
- Employees
- AEON N/A
- MYNA N/A
- Industry
- AEON Biotechnology: Pharmaceutical Preparations
- MYNA
- Sector
- AEON Health Care
- MYNA
- Exchange
- AEON Nasdaq
- MYNA Nasdaq
- Market Cap
- AEON 36.4M
- MYNA 35.9M
- IPO Year
- AEON N/A
- MYNA 2021
- Fundamental
- Price
- AEON $0.61
- MYNA $1.40
- Analyst Decision
- AEON Strong Buy
- MYNA
- Analyst Count
- AEON 1
- MYNA 0
- Target Price
- AEON $5.00
- MYNA N/A
- AVG Volume (30 Days)
- AEON 106.3K
- MYNA 36.5K
- Earning Date
- AEON 11-13-2024
- MYNA 11-26-2024
- Dividend Yield
- AEON N/A
- MYNA N/A
- EPS Growth
- AEON N/A
- MYNA N/A
- EPS
- AEON N/A
- MYNA N/A
- Revenue
- AEON N/A
- MYNA $5,957,776.00
- Revenue This Year
- AEON N/A
- MYNA $216.03
- Revenue Next Year
- AEON N/A
- MYNA $267.22
- P/E Ratio
- AEON N/A
- MYNA N/A
- Revenue Growth
- AEON N/A
- MYNA 21.89
- 52 Week Low
- AEON $0.60
- MYNA $0.66
- 52 Week High
- AEON $17.17
- MYNA $7.58
- Technical
- Relative Strength Index (RSI)
- AEON 28.55
- MYNA 52.07
- Support Level
- AEON $0.60
- MYNA $1.42
- Resistance Level
- AEON $0.88
- MYNA $1.50
- Average True Range (ATR)
- AEON 0.07
- MYNA 0.11
- MACD
- AEON -0.03
- MYNA 0.01
- Stochastic Oscillator
- AEON 2.62
- MYNA 66.67
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
About MYNA Mynaric AG American Depository Shares
Mynaric AG operates in the communication equipment business sector. The company is engaged in the manufacture and sale of products and projects and the provision of services in the field of laser technology, in particular in the aerospace, telematics, and satellite services sectors. It operates in two segments: Air and Space. The space segment comprises CONDOR terminals, and the Air segment comprises HAWK terminals. The company's product portfolio consists of Optical ground stations, Air-to-ground terminals, Air-to-air terminals, Space terminals, and Custom products and subcomponents. Its applications consist of high-altitude networks, remote eyes, satellite constellations, earth observation satellites, and others. Geographically, its key revenue is derived from the United States.